Navigation Links
UN Member States jeopardize international progress on non-communicable disease epidemic

Geneva, 23rd August 2011 The fight against non-communicable diseases (NCDs) such as cancer, diabetes, cardiovascular disease, chronic respiratory disease and liver disease, is at grave risk, because of recent efforts by some countries to stall and weaken critical United Nations negotiations, the European Association for the Study of the Liver (EASL) warned today.

In a letter addressed to Mr Ban Ki-Moon, Dr Margaret Chan and Mr Jose Manuel Barroso, EASL called on them to personally push for progress at the first ever UN High-Level Meeting on the Prevention and Control of Non Communicable Diseases, scheduled for 19󈞀 September in New York.

"The situation is urgent," said Prof. Mark Thursz, Secretary General of EASL. "Sound proposals for clear goals and timelines to tackle devastating diseases, including liver disease, are being systematically deleted, diluted and downgraded by some member states. Urgent action is needed now to put the negotiations back on track."

NCDs are the leading cause of death worldwide each year, causing 36 million deaths in 2008 and accounting for 63 per cent of all global deaths (1). Over the next 20 years, the NCD epidemic is projected to accelerate exponentially, putting enormous strain on families, health systems and economies.

In Europe alone, 86% of all deaths are caused by chronic non-communicable diseases with up to 80% of health-care expenses being allocated to them. What is worse is the fact that the majority of chronic non-communicable diseases can be prevented.

Liver disease is estimated to affect 6% of the EU's population (approx. 29 million people) and is reported to be the EU's 5th biggest killer, accounting for at least one in six deaths. In 2004, the mortality rate for chronic liver diseases was estimated at 14.3 per 100.000 in the EU-25. This means that more than 70,000 Europeans are dying from chronic liver diseases every year. Even more worrying is the fact that the EU statistics do not cover all disease of the liver in one category, e.g. alcohol abuse related deaths and liver cancer are treated separately. Therefore, the actual rate of deaths from liver diseases is certainly much higher than the statistics suggest.

And yet, says EASL, the NCD epidemic could be effectively addressed through the reduction of risk factors principally tobacco use, unhealthy diet, physical inactivity and harmful use of alcohol as well as early detection and timely treatments.

"We have a unique and historic opportunity to change the course of this ticking time bomb and stop millions of people around the world suffering unnecessary pain and hardship", said Prof. Dominique-Charles Valla, EASL's EU Policy Councillor. "To do that, we need governments to agree and act on a common goal."

EASL is calling on the High Level Meeting to agree on:

  • An overarching goal to reduce preventable deaths from NCDs by 25% by 2025
  • A clear timeline for tackling the epidemic of major NCDs, including liver disease
  • A set of specific, evidence-based targets and global indicators
  • A high-level collaborative initiative of governments and UN agencies with civil society to stimulate and assess progress.


Contact: Margaret Walker
European Association for the Study of the Liver

Related medicine news :

1. UC Riverside faculty member elected fellow of Entomological Society of America
2. Military Members Face Raised Risk of Osteoarthritis: Study
3. Black members of Adventist church defy health disparities, study shows
4. Three senior Hebrew University faculty members receive Kaye Awards for innovations
5. As time goes by, it gets tougher to just remember this
6. Monkey See, Monkey Remember
7. IUPUI faculty member to receive national innovative vision research award
8. Smarter systems help busy doctors remember
9. Family Members Caring for Veterans Sacrifice Their Own Health, Jobs
10. ASTRO names radiologist, ABR president Societys 2010 Honorary Member
11. 2010 Resource Planning Summit to offer $695 Registration Fee for PDMA, PMI, BIOCOM and ASAPM Members
Post Your Comments:
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: